I think if you listened to the FDA briefing, they absolutely had a choice. This isn’t even a mandate. No one needs to stop administering J&J if they want to. All they’re doing here is buying time to instruct clinicians with guidance on how to treat potential patients w/a risk of side affects. There were much better ways to communicate that guidance.
4 Likes
Snark upon snark upon snark, ad infinitum.
It boggles the mind.
4 Likes
Yeah, some people here don’t have the extension for that.
4 Likes
I love your work.
2 Likes
Just heard from a PA (Philly area) person who was scheduled for today - appointment still on, same location & will now be getting the Pfizer vaccine. Sounds like a seamless shifting of gears.
4 Likes
Yes same in NY for state run facilities.
3 Likes
If it helps to calm your nerves, ask your primary care physician about heparin and warfarin. The former prevents blood clot formation and is typically given via subdermal injection in the hospital, so it can be costly. It’s often given subsequent to blood clot formation as a method to keep the clot from getting any larger. Warfarin in also typically used for long term suppression of blood clot formation and is very cheap, but requires titration as part of a test using INR blood measurements. Warfarin is used on a long term basis to prevent the formation of blood clots.
4 Likes
It’s actually the right comparison except J&J has lower reported incidents of such side affects than AZ. there is a real cost-benefit analysis here. You’re seeing it in Europe where low supply and vaccine hesitancy have left them behind schedule with the continued risk of COVID spread/deaths.
3 Likes
Are you angry at the vaccine or hearing frequency?
Sorry. But - high efficacy of vaccines have tradeoffs. These usually have to do with side effects. We need to know about them. That’s the difference between rumors the antivaxers trade in and science.
There was a worry, for a while now as many medical journals in EU attest that Pfizer and especially Moderna cause other severe side effects, having to do with strokes, this action today is reassuring. It means the government is watching. And since they are, if that would be the case, they would have noticed.
For now, wait. Let’s see what they find. It’s a process we need to go thru. Otherwise the reliability of science is shut.
3 Likes
“A dog’s your best friend”
Unless it’s a drug sniffing dog. Trust me!
2 Likes
and you can save big by getting the generic version at your local hardware store.
2 Likes
I see Europe. All the freaking time. I have family there. In few countries.
The pause didn’t cause hesitancy. The irresponsible reporting by gossip mongers on internets caused hesitancy for a while, since gone. Because the science went and explained on regular media. Over and over. And the governments did the same, thou not in bonkers EU countries. The delays in vaccination effort in EU has little to do with vaccine hesitancy.
2 Likes
Yes, there is – more than one, in fact.
You’re talking about only this one: What to do with this vaccine at this time?
Another cost-benefit analysis: What to do about the new data at this time?
And yet another: What to do if the agencies do not release the data and then someone else does?
Think about these costs and benefits as well.
1 Like
You release the data. You conduct the review in parallel. The fact that the pause is for a few days tells us that the pause itself is unnecessary and causes more harm than good.
1 Like
I got J and J a month ago. To me the tiny risk of a blood clot is outweighed by the benefits of the free microchipping, and Bill Gates’ soothing voice in my head.
5 Likes
Did you get vaccinated with J&J or one of the others?
1 Like
deleted
1 Like
Not clear how anything “tells us” this.
1 Like
Yeah the leading cause of death on the planet is birth. If you get born you will die.
6 Likes
UK had one approach. Rest of Europe had another. Tell me which is better. Have you seen the stats on the % of 50+ in the UK that are vaccinated with at least 1 dose? It’s stunningly good.
2 Likes